Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC

Publication Date

2025

Content Type

Article

PubMed ID:

52025

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS